Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction
- PMID: 26103027
- DOI: 10.1001/jama.2015.6409
Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction
Abstract
Importance: Implantable cardioverter-defibrillators (ICDs) are not recommended within 40 days of myocardial infarction (MI); thus, ICD implantation might not be considered during the post-MI care transition.
Objective: To examine ICD implantation rates and associated mortality among older MI patients with low ejection fraction (EF).
Design, setting, and participants: Retrospective observational study of Medicare beneficiaries with an EF of 35% or less after MI, treated at 441 US hospitals between 2007 and 2010, excluding patients with prior ICD implantation. Follow-up data were available through December 2010.
Exposures: ICD implantation within 1 year of MI vs no ICD implantation within 1 year of MI.
Main outcomes and measures: Patient characteristics associated with receiving an ICD within 1 year after discharge and 2-year mortality associated with ICD implantation.
Results: Among 10,318 MI patients with EF of 35%or lower, the cumulative 1-year ICD implantation rate was 8.1% (95%CI, 7.6%-8.7%). Patients with ICD implantation were more likely to have prior coronary artery bypass graft procedures, higher peak troponin levels, in-hospital cardiogenic shock, and cardiology follow-up within 2 weeks after discharge relative to patients who did not receive an ICD within 1 year. Implantation of ICD was associated with lower 2-year mortality (15.3 events per 100 patient-years [128 deaths in 838 patient-years] vs 26.4 events per 100 patient-years [3033 deaths in 11 479 patient-years]; adjusted HR, 0.64; 95%CI, 0.53-0.78). [table: see text]
Conclusions and relevance: In this large registry study of older patients who experienced MI from 2007-2010, fewer than 1 in 10 eligible patients with low EF received an ICD within 1 year after MI, although ICD implantation was associated with lower risk-adjusted mortality at 2 years. Additional research is needed to determine evidence-based approaches to increase ICD implantation among eligible patients.
Comment in
-
Underutilization of Implantable Cardioverter-Defibrillators in Older Patients.JAMA. 2015 Jun 23-30;313(24):2429-30. doi: 10.1001/jama.2015.6408. JAMA. 2015. PMID: 26103025 No abstract available.
-
Device therapy: Saving lives with appropriate ICD therapy in elderly patients.Nat Rev Cardiol. 2015 Sep;12(9):504-6. doi: 10.1038/nrcardio.2015.114. Epub 2015 Jul 28. Nat Rev Cardiol. 2015. PMID: 26216622 No abstract available.
-
Use of Implantable Cardioverter-Defibrillators Among Medicare Patients.JAMA. 2015 Nov 3;314(17):1873-4. doi: 10.1001/jama.2015.12212. JAMA. 2015. PMID: 26529167 No abstract available.
-
Use of Implantable Cardioverter-Defibrillators Among Medicare Patients--Reply.JAMA. 2015 Nov 3;314(17):1874-5. doi: 10.1001/jama.2015.12218. JAMA. 2015. PMID: 26529168 No abstract available.
Similar articles
-
Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction.Circulation. 2017 Jan 3;135(1):38-47. doi: 10.1161/CIRCULATIONAHA.116.022359. Epub 2016 Nov 16. Circulation. 2017. PMID: 27881561
-
Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥65 Years of Age With a Low Ejection Fraction After Coronary Revascularization.Am J Cardiol. 2021 Jan 1;138:26-32. doi: 10.1016/j.amjcard.2020.09.056. Epub 2020 Oct 15. Am J Cardiol. 2021. PMID: 33068540
-
Outcomes in patients with sustained ventricular tachyarrhythmias occurring within 48 h of acute myocardial infarction: when is ICD appropriate?Europace. 2014 Dec;16(12):1759-66. doi: 10.1093/europace/euu138. Epub 2014 Aug 6. Europace. 2014. PMID: 25100756
-
Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators.Future Cardiol. 2010 May;6(3):315-23. doi: 10.2217/fca.10.15. Future Cardiol. 2010. PMID: 20462338 Review.
-
Identifying high-risk post-infarction patients by autonomic testing - Below the tip of the iceberg.Int J Cardiol. 2017 Jun 15;237:19-21. doi: 10.1016/j.ijcard.2017.03.087. Epub 2017 Mar 18. Int J Cardiol. 2017. PMID: 28343763 Review.
Cited by
-
Echocardiographic Predictors of Improvement of Left Ventricular Ejection Fraction below 35% in Patients with ST-Segment Elevation Myocardial Infarction.J Clin Med. 2024 Jul 9;13(14):4016. doi: 10.3390/jcm13144016. J Clin Med. 2024. PMID: 39064056 Free PMC article.
-
Efficacy and safety of implantable cardioverter-defibrillator implantation in the elderly-The I-70 Study: A randomized clinical trial.Heart Rhythm O2. 2024 Apr 27;5(6):365-373. doi: 10.1016/j.hroo.2024.04.010. eCollection 2024 Jun. Heart Rhythm O2. 2024. PMID: 38984364 Free PMC article.
-
Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction ≤35 % at least 40 days after acute myocardial infarction.Am Heart J Plus. 2022 Jul;19:100186. doi: 10.1016/j.ahjo.2022.100186. Am Heart J Plus. 2022. PMID: 37886349 Free PMC article.
-
Managed Care after Acute Myocardial Infarction (MC-AMI) Reduces Total Mortality in 12-Month Follow-Up-Results from a Poland's National Health Fund Program of Comprehensive Post-MI Care-A Population-Wide Analysis.J Clin Med. 2020 Sep 30;9(10):3178. doi: 10.3390/jcm9103178. J Clin Med. 2020. PMID: 33008030 Free PMC article.
-
Matching with time-dependent treatments: A review and look forward.Stat Med. 2020 Jul 30;39(17):2350-2370. doi: 10.1002/sim.8533. Epub 2020 Apr 3. Stat Med. 2020. PMID: 32242973 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
